These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25212020)

  • 1. [Roles of microglia and immune receptors in Alzheimer's disease].
    He X; Sun BG
    Yao Xue Xue Bao; 2014 Jun; 49(6):774-80. PubMed ID: 25212020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
    Martin E; Boucher C; Fontaine B; Delarasse C
    Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytes and Alzheimer's disease.
    Feng Y; Li L; Sun XH
    Neurosci Bull; 2011 Apr; 27(2):115-22. PubMed ID: 21441973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.
    Spangenberg EE; Green KN
    Brain Behav Immun; 2017 Mar; 61():1-11. PubMed ID: 27395435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction.
    Orre M; Kamphuis W; Osborn LM; Jansen AHP; Kooijman L; Bossers K; Hol EM
    Neurobiol Aging; 2014 Dec; 35(12):2746-2760. PubMed ID: 25002035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia in Alzheimer's disease: A target for immunotherapy.
    Wang S; Colonna M
    J Leukoc Biol; 2019 Jul; 106(1):219-227. PubMed ID: 30725482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM1 facilitates microglial phagocytosis of amyloid beta.
    Jiang T; Zhang YD; Gao Q; Zhou JS; Zhu XC; Lu H; Shi JQ; Tan L; Chen Q; Yu JT
    Acta Neuropathol; 2016 Nov; 132(5):667-683. PubMed ID: 27670763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.
    Keren-Shaul H; Spinrad A; Weiner A; Matcovitch-Natan O; Dvir-Szternfeld R; Ulland TK; David E; Baruch K; Lara-Astaiso D; Toth B; Itzkovitz S; Colonna M; Schwartz M; Amit I
    Cell; 2017 Jun; 169(7):1276-1290.e17. PubMed ID: 28602351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the Role of TREM2 in Alzheimer's Disease.
    Ulrich JD; Ulland TK; Colonna M; Holtzman DM
    Neuron; 2017 Apr; 94(2):237-248. PubMed ID: 28426958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response.
    Jiang T; Zhang YD; Gao Q; Ou Z; Gong PY; Shi JQ; Wu L; Zhou JS
    Inflammation; 2018 Jun; 41(3):811-823. PubMed ID: 29362997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia in Alzheimer's disease.
    Sarlus H; Heneka MT
    J Clin Invest; 2017 Sep; 127(9):3240-3249. PubMed ID: 28862638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
    El Khoury J; Luster AD
    Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights on the role of microglia in synaptic pruning in health and disease.
    Hong S; Dissing-Olesen L; Stevens B
    Curr Opin Neurobiol; 2016 Feb; 36():128-34. PubMed ID: 26745839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
    Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
    J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
    Lue LF; Walker DG
    J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer's Disease Genetics.
    Podleśny-Drabiniok A; Marcora E; Goate AM
    Trends Neurosci; 2020 Dec; 43(12):965-979. PubMed ID: 33127097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease.
    Gao C; Shen X; Tan Y; Chen S
    J Neuroinflammation; 2022 Sep; 19(1):215. PubMed ID: 36058959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
    Cai Z; Hussain MD; Yan LJ
    Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats.
    Takata K; Kitamura Y; Yanagisawa D; Morikawa S; Morita M; Inubushi T; Tsuchiya D; Chishiro S; Saeki M; Taniguchi T; Shimohama S; Tooyama I
    FEBS Lett; 2007 Feb; 581(3):475-8. PubMed ID: 17240371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.